Antibacterial action of lactoferricin B like peptide against Escherichia coli: reactive oxygen species-induced apoptosis-like death

Journal of Applied Microbiology
B LeeDong Gun Lee

Abstract

Emergence and rapid dissemination of antibiotic-resistant bacteria is becoming a severe problem to public health. The search for antimicrobial substitutes for antibiotics is necessary. Lactoferricin B like peptide (LBLP) is a 23-mer antimicrobial peptide (AMP), derived from the big centipede Scolopendra subspinipes mutilans. Although its antifungal effect and its mechanism have been reported, the antibacterial activity has not yet been elucidated. In this study, we investigated antibacterial activity of LBLP and its mode of action. LBLP showed potent antibacterial effect against pathogenic bacteria Escherichia coli and did not show haemolytic activity against human erythrocyte. The general antimicrobial mechanism of AMP is to disrupt the cell membrane, however, LBLP exerted its antibacterial activity by causing apoptosis-like death through reactive oxygen species (ROS) generation. LBLP-treated E. coli cells exhibited hallmarks of apoptosis, such as membrane depolarization, DNA fragmentation, caspase-like protein activation and phosphatidylserine exposure. These apoptotic features were attenuated by pretreatment of NAC, a representative ROS scavenger. These results demonstrate that LBLP exerted its antibacterial activity by gene...Continue Reading

References

Jun 3, 1988·Science·J A Imlay, S Linn
Jul 27, 2001·The Journal of Biological Chemistry·L ZhangR E Hancock
Dec 20, 2002·Biopolymers·Yechiel Shai
Feb 11, 2005·Nature Reviews. Microbiology·Kim A Brogden
Oct 12, 2005·Archives of Medical Research·Alfonso J Alanis
Jul 19, 2006·Clinical Microbiology Reviews·Håvard JenssenRobert E W Hancock
Sep 7, 2007·Cell·Michael A KohanskiJames J Collins
Sep 13, 2007·Nature Reviews. Molecular Cell Biology·Benoît D'Autréaux, Michel B Toledano
Nov 10, 2010·PLoS Pathogens·Brian M PetersMary Ann Jabra-Rizk
Apr 13, 2011·Trends in Plant Science·Ron MittlerFrank Van Breusegem
Dec 17, 2011·Nature Reviews. Drug Discovery·Christopher D FjellGisbert Schneider
Jul 4, 2012·Journal of Biosciences·N R Jena
Jun 5, 2013·Methods in Molecular Biology·Daniel J Dwyer, Jonathan A Winkler
Aug 28, 2013·Cell Research·Guillermo Mariño, Guido Kroemer
May 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Daniel J DwyerJames J Collins
Jul 17, 2014·MBio·Ariel ErentalHanna Engelberg-Kulka
Dec 30, 2014·Journal of Microbiology and Biotechnology·Juneyoung Lee, Dong Gun Lee
Jan 15, 2016·Current Biology : CB·Ling-Juan Zhang, Richard L Gallo
May 7, 2016·International Journal of Molecular Sciences·Shuai WangShiyan Qiao
May 9, 2016·Trends in Biochemical Sciences·Jason C Bell, Stephen C Kowalczykowski
May 11, 2016·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Jens Rolff, Paul Schmid-Hempel
May 18, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·D I AnderssonJ Z Kubicek-Sutherland
May 18, 2016·Accounts of Chemical Research·Marc-Antoine Sani, Frances Separovic
Dec 26, 2016·Methods in Molecular Biology·Alberto Oddo, Paul R Hansen
Jan 17, 2017·Trends in Microbiology·Heleen Van Acker, Tom Coenye
Feb 18, 2017·Trends in Pharmacological Sciences·Giulia GuidottiDaniela Rossi
May 19, 2017·FEMS Microbiology Reviews·Shiri Navon-VeneziaAlessandra Carattoli
Nov 6, 2018·The International Journal of Biochemistry & Cell Biology·JiEun Yun, Dong Gun Lee
Feb 27, 2019·The Journal of Microbiology·So Youn KimYou-Hee Cho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis